Suprenza

Suprenza is a brand name of phentermine, approved by the FDA in the following formulation(s):

SUPRENZA (phentermine hydrochloride - tablet, orally disintegrating; oral)

• 
  Manufacturer: CITIUS PHARMS
  
  Approval date: June 13, 2011
  
  Strength(s): 15MG, 30MG ^[RLD]

Has a generic version of Suprenza been approved?

No. There is currently no therapeutically equivalent version of Suprenza available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Suprenza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
  Patent 6,149,938
  Issued: November 21, 2000
  Inventor(s): Bonadeo; Daniele & Ciccarello; Franco & Pagano; Aberto
  Assignee(s): Elan Pharma International Limited
  A process for making a granulate composition suitable to the preparation of an oral solid form that can disintegrate rapidly inside the buccal cavity is provided as well as the granulate compositions and obtained.
  
  Patent expiration dates:
  
  
  • July 23, 2018
    
    ✓ 
    Drug product
  
  

See also...

• Phentermine Consumer Information (Drugs.com)
• Phentermine Consumer Information (Wolters Kluwer)
• Phentermine Resin Consumer Information (Wolters Kluwer)
• Phentermine Consumer Information (Cerner Multum)
• Phentermine AHFS DI Monographs (ASHP)
• Phentermine Hydrochloride AHFS DI Monographs (ASHP)